Access to the PDF text

Archives of cardiovascular diseases
Volume 104, n° 12
pages 669-676 (décembre 2011)
Doi : 10.1016/j.acvd.2011.09.001
Received : 1 September 2011 ;  accepted : 1 September 2011
Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemostasis
Chirurgies et actes invasifs chez les patients traités au long cours par un anticoagulant oral anti-IIa ou anti-Xa direct. Recommandations du Groupe d’intérêt en hémostase périopératoire (GIHP) et du Groupe d’études sur l’hémostase et la thrombose (GEHT)

Figure 1

Figure 1 : 

Example of a protocol for creating a direct oral anticoagulant therapeutic window for surgery or an invasive procedure with a low risk of bleeding (A) or a moderate or high risk of bleeding (B). In the case of bridging with a heparin (situation B), no overlap of the two anticoagulants is allowed, either preoperatively or postoperatively. Direct oral anticoagulant (DOA); low molecular-weight heparin (LMWH); unfractionated heparin (UFH); venous thromboembolism (VTE).

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline